These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 15562510)

  • 21. Neuronal inclusions in sporadic motor neuron disease are negative for alpha-synuclein.
    Sasaki S; Komori T; Iwata M
    Neurosci Lett; 2006 Apr 10-17; 397(1-2):15-9. PubMed ID: 16406315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tuft-shaped astrocytes in Lewy body disease.
    Hishikawa N; Hashizume Y; Yoshida M; Niwa J; Tanaka F; Sobue G
    Acta Neuropathol; 2005 Apr; 109(4):373-80. PubMed ID: 15668789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Occurrence of neuronal inclusions combined with increased nigral expression of alpha-synuclein within dopaminergic neurons following treatment with amphetamine derivatives in mice.
    Fornai F; Lenzi P; Ferrucci M; Lazzeri G; di Poggio AB; Natale G; Busceti CL; Biagioni F; Giusiani M; Ruggieri S; Paparelli A
    Brain Res Bull; 2005 May; 65(5):405-13. PubMed ID: 15833595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alpha-synuclein pathology in the spinal cords of neurologically asymptomatic aged individuals.
    Klos KJ; Ahlskog JE; Josephs KA; Apaydin H; Parisi JE; Boeve BF; DeLucia MW; Dickson DW
    Neurology; 2006 Apr; 66(7):1100-2. PubMed ID: 16606927
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intralaminar nuclei of the thalamus in Lewy body diseases.
    Brooks D; Halliday GM
    Brain Res Bull; 2009 Feb; 78(2-3):97-104. PubMed ID: 18804518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases.
    Duda JE; Giasson BI; Mabon ME; Lee VM; Trojanowski JQ
    Ann Neurol; 2002 Aug; 52(2):205-10. PubMed ID: 12210791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lysosomal pathology associated with alpha-synuclein accumulation in transgenic models using an eGFP fusion protein.
    Rockenstein E; Schwach G; Ingolic E; Adame A; Crews L; Mante M; Pfragner R; Schreiner E; Windisch M; Masliah E
    J Neurosci Res; 2005 Apr; 80(2):247-59. PubMed ID: 15765523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. α-Synuclein pathology in the amyotrophic lateral sclerosis/parkinsonism dementia complex in the Kii Peninsula, Japan.
    Kokubo Y; Taniguchi A; Hasegawa M; Hayakawa Y; Morimoto S; Yoneda M; Hirokawa Y; Shiraishi T; Saito Y; Murayama S; Kuzuhara S
    J Neuropathol Exp Neurol; 2012 Jul; 71(7):625-30. PubMed ID: 22710962
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alpha-synuclein pathology affecting Bergmann glia of the cerebellum in patients with alpha-synucleinopathies.
    Piao YS; Mori F; Hayashi S; Tanji K; Yoshimoto M; Kakita A; Wakabayashi K; Takahashi H
    Acta Neuropathol; 2003 Apr; 105(4):403-9. PubMed ID: 12624794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alpha-synuclein in motor neuron disease: an immunohistologic study.
    Doherty MJ; Bird TD; Leverenz JB
    Acta Neuropathol; 2004 Feb; 107(2):169-75. PubMed ID: 14648076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreases in soluble alpha-synuclein in frontal cortex correlate with cognitive decline in the elderly.
    Wang DS; Bennett DA; Mufson E; Cochran E; Dickson DW
    Neurosci Lett; 2004 Apr; 359(1-2):104-8. PubMed ID: 15050722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuropathology of Parkinson's disease dementia and dementia with Lewy bodies with reference to striatal pathology.
    Tsuboi Y; Uchikado H; Dickson DW
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S221-4. PubMed ID: 18267239
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A critical reappraisal of current staging of Lewy-related pathology in human brain.
    Jellinger KA
    Acta Neuropathol; 2008 Jul; 116(1):1-16. PubMed ID: 18592254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunoexpression of 14-3-3 proteins in glial cytoplasmic inclusions of multiple system atrophy.
    Komori T; Ishizawa K; Arai N; Hirose T; Mizutani T; Oda M
    Acta Neuropathol; 2003 Jul; 106(1):66-70. PubMed ID: 12669242
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of alpha-synuclein in neurodegenerative diseases.
    Bennett MC
    Pharmacol Ther; 2005 Mar; 105(3):311-31. PubMed ID: 15737408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tau and alpha-synuclein brainstem pathology in Alzheimer disease: relation with extrapyramidal signs.
    Attems J; Quass M; Jellinger KA
    Acta Neuropathol; 2007 Jan; 113(1):53-62. PubMed ID: 17031655
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuropathology of primary restless leg syndrome: absence of specific tau- and alpha-synuclein pathology.
    Pittock SJ; Parrett T; Adler CH; Parisi JE; Dickson DW; Ahlskog JE
    Mov Disord; 2004 Jun; 19(6):695-9. PubMed ID: 15197711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistochemical localization of NUB1, a synphilin-1-binding protein, in neurodegenerative disorders.
    Tanji K; Mori F; Kakita A; Zhang H; Kito K; Kamitani T; Takahashi H; Wakabayashi K
    Acta Neuropathol; 2007 Oct; 114(4):365-71. PubMed ID: 17549501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A quantitative investigation of neuronal cytoplasmic and intranuclear inclusions in the pontine and inferior olivary nuclei in multiple system atrophy.
    Nishie M; Mori F; Yoshimoto M; Takahashi H; Wakabayashi K
    Neuropathol Appl Neurobiol; 2004 Oct; 30(5):546-54. PubMed ID: 15488031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atypical parkinsonism combining alpha-synuclein inclusions and polyglucosan body disease.
    Krim E; Vital A; Macia F; Yekhlef F; Tison F
    Mov Disord; 2005 Feb; 20(2):200-4. PubMed ID: 15382212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.